From: Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
 | SCLC1 | SR-2 | SCLCB | SCLCBC | SCLCL | SCLCR | SCLCA | NSCLCW | NSCLCG |
---|---|---|---|---|---|---|---|---|---|
Rapamycin ug/ml | 0.66 ± 0.1 | 0.1 ± .0.05 | 0.05 ± 0.02 | 0.09 ± 0.03 | 0.2 ± 0.006 | >1 | >1 | ND* | ND* |
CCI-779 ug/ml | 0.07 ± 0.02 | 0.06 ± 0.01 | 0.04 ± ..0.01 | 0.05 ± 0.02 | 0.3 ± 0.1 | 6.9 ± 2.4 | 7.5 ± 1.5 | 0.3 ± 0.1 | 0.5 ± 0.2 |